Trace amine-associated receptor 1-Family archetype or iconoclast?

David Grandy

    Research output: Contribution to journalArticle

    120 Citations (Scopus)

    Abstract

    Interest has recently been rekindled in receptors that are activated by low molecular weight, noncatecholic, biogenic amines that are typically found as trace constituents of various vertebrate and invertebrate tissues and fluids. The timing of this resurgent focus on receptors activated by the "trace amines" (TA) β-phenylethylamine (PEA), tyramine (TYR), octopamine (OCT), synephrine (SYN), and tryptamine (TRYP) is the direct result of 2 publications that appeared in 2001 describing the cloning of a novel G protein-coupled receptor (GPCR) referred to by their discoverers Borowsky et al. as TA1 and Bunzow et al. as TA receptor 1 (TAR1). When heterologously expressed in Xenopus laevis oocytes and various eukaryotic cell lines, recombinant rodent and human TAR dose-dependently couple to the stimulation of adenosine 3′,5′-monophosphate (cAMP) production. Structure-activity profiling based on this functional response has revealed that in addition to the TA, other biologically active compounds containing a 2-carbon aliphatic side chain linking an amino group to at least 1 benzene ring are potent and efficacious TA receptor agonists with amphetamine (AMPH), methamphetamine, 3-iodothyronamine, thyronamine, and dopamine (DA) among the most notable. Almost 100 years after the search for TAR began, numerous TA1/TAR1-related sequences, now called TA-associated receptors (TAAR), have been identified in the genome of every species of vertebrate examined to date. Consequently, even though heterologously expressed TAAR1 fits the pharmacological criteria established for a bona fide TAR, a major challenge for those working in the field is to discern the in vivo pharmacology and physiology of each purported member of this extended family of GPCR. Only then will it be possible to establish whether TAAR1 is the family archetype or an iconoclast.

    Original languageEnglish (US)
    Pages (from-to)355-390
    Number of pages36
    JournalPharmacology and Therapeutics
    Volume116
    Issue number3
    DOIs
    StatePublished - Dec 2007

    Fingerprint

    Amines
    G-Protein-Coupled Receptors
    Vertebrates
    Synephrine
    Pharmacology
    Octopamine
    Phenethylamines
    Tyramine
    Biogenic Amines
    Methamphetamine
    Xenopus laevis
    Eukaryotic Cells
    Amphetamine
    Invertebrates
    Benzene
    Adenosine
    Oocytes
    Publications
    Organism Cloning
    Rodentia

    Keywords

    • Iodothyronamine
    • Mental health
    • Noncatecholic phenylethylamines
    • Orphan receptor
    • Phenethylamine
    • Psychostimulant
    • Schizophrenia
    • Trace amine
    • Tyramine

    ASJC Scopus subject areas

    • Pharmacology

    Cite this

    Trace amine-associated receptor 1-Family archetype or iconoclast? / Grandy, David.

    In: Pharmacology and Therapeutics, Vol. 116, No. 3, 12.2007, p. 355-390.

    Research output: Contribution to journalArticle

    @article{09039ac8f1654023835949cb767df2bb,
    title = "Trace amine-associated receptor 1-Family archetype or iconoclast?",
    abstract = "Interest has recently been rekindled in receptors that are activated by low molecular weight, noncatecholic, biogenic amines that are typically found as trace constituents of various vertebrate and invertebrate tissues and fluids. The timing of this resurgent focus on receptors activated by the {"}trace amines{"} (TA) β-phenylethylamine (PEA), tyramine (TYR), octopamine (OCT), synephrine (SYN), and tryptamine (TRYP) is the direct result of 2 publications that appeared in 2001 describing the cloning of a novel G protein-coupled receptor (GPCR) referred to by their discoverers Borowsky et al. as TA1 and Bunzow et al. as TA receptor 1 (TAR1). When heterologously expressed in Xenopus laevis oocytes and various eukaryotic cell lines, recombinant rodent and human TAR dose-dependently couple to the stimulation of adenosine 3′,5′-monophosphate (cAMP) production. Structure-activity profiling based on this functional response has revealed that in addition to the TA, other biologically active compounds containing a 2-carbon aliphatic side chain linking an amino group to at least 1 benzene ring are potent and efficacious TA receptor agonists with amphetamine (AMPH), methamphetamine, 3-iodothyronamine, thyronamine, and dopamine (DA) among the most notable. Almost 100 years after the search for TAR began, numerous TA1/TAR1-related sequences, now called TA-associated receptors (TAAR), have been identified in the genome of every species of vertebrate examined to date. Consequently, even though heterologously expressed TAAR1 fits the pharmacological criteria established for a bona fide TAR, a major challenge for those working in the field is to discern the in vivo pharmacology and physiology of each purported member of this extended family of GPCR. Only then will it be possible to establish whether TAAR1 is the family archetype or an iconoclast.",
    keywords = "Iodothyronamine, Mental health, Noncatecholic phenylethylamines, Orphan receptor, Phenethylamine, Psychostimulant, Schizophrenia, Trace amine, Tyramine",
    author = "David Grandy",
    year = "2007",
    month = "12",
    doi = "10.1016/j.pharmthera.2007.06.007",
    language = "English (US)",
    volume = "116",
    pages = "355--390",
    journal = "Pharmacology and Therapeutics",
    issn = "0163-7258",
    publisher = "Elsevier Inc.",
    number = "3",

    }

    TY - JOUR

    T1 - Trace amine-associated receptor 1-Family archetype or iconoclast?

    AU - Grandy, David

    PY - 2007/12

    Y1 - 2007/12

    N2 - Interest has recently been rekindled in receptors that are activated by low molecular weight, noncatecholic, biogenic amines that are typically found as trace constituents of various vertebrate and invertebrate tissues and fluids. The timing of this resurgent focus on receptors activated by the "trace amines" (TA) β-phenylethylamine (PEA), tyramine (TYR), octopamine (OCT), synephrine (SYN), and tryptamine (TRYP) is the direct result of 2 publications that appeared in 2001 describing the cloning of a novel G protein-coupled receptor (GPCR) referred to by their discoverers Borowsky et al. as TA1 and Bunzow et al. as TA receptor 1 (TAR1). When heterologously expressed in Xenopus laevis oocytes and various eukaryotic cell lines, recombinant rodent and human TAR dose-dependently couple to the stimulation of adenosine 3′,5′-monophosphate (cAMP) production. Structure-activity profiling based on this functional response has revealed that in addition to the TA, other biologically active compounds containing a 2-carbon aliphatic side chain linking an amino group to at least 1 benzene ring are potent and efficacious TA receptor agonists with amphetamine (AMPH), methamphetamine, 3-iodothyronamine, thyronamine, and dopamine (DA) among the most notable. Almost 100 years after the search for TAR began, numerous TA1/TAR1-related sequences, now called TA-associated receptors (TAAR), have been identified in the genome of every species of vertebrate examined to date. Consequently, even though heterologously expressed TAAR1 fits the pharmacological criteria established for a bona fide TAR, a major challenge for those working in the field is to discern the in vivo pharmacology and physiology of each purported member of this extended family of GPCR. Only then will it be possible to establish whether TAAR1 is the family archetype or an iconoclast.

    AB - Interest has recently been rekindled in receptors that are activated by low molecular weight, noncatecholic, biogenic amines that are typically found as trace constituents of various vertebrate and invertebrate tissues and fluids. The timing of this resurgent focus on receptors activated by the "trace amines" (TA) β-phenylethylamine (PEA), tyramine (TYR), octopamine (OCT), synephrine (SYN), and tryptamine (TRYP) is the direct result of 2 publications that appeared in 2001 describing the cloning of a novel G protein-coupled receptor (GPCR) referred to by their discoverers Borowsky et al. as TA1 and Bunzow et al. as TA receptor 1 (TAR1). When heterologously expressed in Xenopus laevis oocytes and various eukaryotic cell lines, recombinant rodent and human TAR dose-dependently couple to the stimulation of adenosine 3′,5′-monophosphate (cAMP) production. Structure-activity profiling based on this functional response has revealed that in addition to the TA, other biologically active compounds containing a 2-carbon aliphatic side chain linking an amino group to at least 1 benzene ring are potent and efficacious TA receptor agonists with amphetamine (AMPH), methamphetamine, 3-iodothyronamine, thyronamine, and dopamine (DA) among the most notable. Almost 100 years after the search for TAR began, numerous TA1/TAR1-related sequences, now called TA-associated receptors (TAAR), have been identified in the genome of every species of vertebrate examined to date. Consequently, even though heterologously expressed TAAR1 fits the pharmacological criteria established for a bona fide TAR, a major challenge for those working in the field is to discern the in vivo pharmacology and physiology of each purported member of this extended family of GPCR. Only then will it be possible to establish whether TAAR1 is the family archetype or an iconoclast.

    KW - Iodothyronamine

    KW - Mental health

    KW - Noncatecholic phenylethylamines

    KW - Orphan receptor

    KW - Phenethylamine

    KW - Psychostimulant

    KW - Schizophrenia

    KW - Trace amine

    KW - Tyramine

    UR - http://www.scopus.com/inward/record.url?scp=36248952213&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=36248952213&partnerID=8YFLogxK

    U2 - 10.1016/j.pharmthera.2007.06.007

    DO - 10.1016/j.pharmthera.2007.06.007

    M3 - Article

    C2 - 17888514

    AN - SCOPUS:36248952213

    VL - 116

    SP - 355

    EP - 390

    JO - Pharmacology and Therapeutics

    JF - Pharmacology and Therapeutics

    SN - 0163-7258

    IS - 3

    ER -